Simplify Logo
Achira

Achira

Atomistic drug-discovery simulation platform

Machine Learning Research Scientist - Machine Learning Research Scientist, Generative AI

Full-TimeUpdated on 9/17/2026
$164.6k - $259k/yr
Mid
San Francisco, CA, USA+1 more

More locations: New York, NY, USA

Hybrid

Hybrid work is required in the office; New York-based employees travel to San Francisco as needed. Travel also includes conferences and corporate on-site activities.

About the job

Requirements
  • Demonstrated research impact through conference talks or publications in machine learning venues, open-source contributions, or released models.
  • Strong interdisciplinary communication and presentation skills, with the ability to translate ideas and concepts to colleagues from non-machine-learning backgrounds.
  • Proficiency in Python and modern machine learning frameworks, including PyTorch and JAX.
  • Experience collaborating on research projects across multi-person teams.
  • Comfort working on frontier problems in physical artificial intelligence.
Responsibilities
  • Invent advanced sampling and simulation methods integrating probabilistic inference, deep learning, and reinforcement learning for efficient exploration and simulation of learned energy landscapes for molecular systems.
  • Design and train frontier generative models using diffusion, autoregressive, flow-based, and latent-variable architectures.
  • Build models that map between data distributions to bridge the gap between simulation and reality.
  • Prototype, benchmark, and iterate rapidly to transform research ideas into reusable and scalable components across the ecosystem.
  • Collaborate with physicists and chemists to ensure models are grounded in real physics.
  • Work with research engineers and the infrastructure team to identify the support needed to deliver effective results.
Desired Qualifications
  • Professional post-degree machine learning research experience in an industry setting.
  • Experience working with models operating on three-dimensional point clouds and dynamic data.
  • Experience with sequential Monte Carlo methods.
  • Experience with probabilistic programming.
  • Experience with pre-training, mid-training, and post-training stages of model development, especially reinforcement learning.
  • Working knowledge of statistical mechanics, including sampling, estimators, and the Crooks/Jarzynski perspective of nonequilibrium statistical mechanics.
  • Experience working in or with researchers in computational chemistry, biology, or materials science.
  • Experience with multi-cloud distributed compute systems.
  • Experience working with distributed teams across multiple sites.

About the company

Achira develops atomistic foundation simulation models for drug discovery, combining geometric deep learning, physics, quantum chemistry, and statistical mechanics to create advanced potentials and generative models. These models produce large synthetic datasets free from experimental artifacts, enabling true inverse design where researchers optimize compounds from desired properties. Achira serves pharmaceutical and biotech clients through partnerships, licensing, and collaborations, differentiating itself by integrating physics-based simulations with data-driven learning to mitigate data scarcity and high costs. The company's goal is to accelerate and make drug discovery more reliable by enabling inverse design that reduces time and expenses in identifying promising compounds.

Company Size

11-50

Company Stage

Seed

Total Funding

$33M

Headquarters

New York City, New York

Founded

2024

Get referred to Achira

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Achira raised $33 million from Dimension, NVIDIA, Amplify, and Compound in 2025.
  • June 2026 NVIDIA collaboration signals active distribution leverage and technical validation.
  • Hiring for ML researchers and software engineers shows continued expansion across core product functions.

What critics are saying

  • Achira has no disclosed commercial customers, leaving revenue unproven beyond partnerships.
  • Drug-discovery validation cycles take years; first models were only expected during 2025.
  • If physics-grounded models underperform experiments, Achira becomes an expensive research lab, not a business.

What makes Achira unique

  • Achira blends atomistic simulation, quantum chemistry, and geometric deep learning for molecular world models.
  • Founders John Chodera and Theofanis Karaletsos bring elite drug discovery and ML credentials.
  • NVIDIA-backed BioNeMo collaboration positions Achira inside life-sciences infrastructure, not a standalone model vendor.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Hybrid Work Options

Flexible Work Hours

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

PTO/vacation

Paid Vacation

Paid Holidays

Unlimited Paid Time Off

401(k) Retirement Plan

Stock Options

Company Equity

Wellness Program

Mental Health Support

Gym Membership

Conference Attendance Budget

Professional Development Budget

Phone/Internet Stipend

Home Office Stipend

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Confluence

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

12%
The National Herald
Apr 10th, 2025
Achira AI Secures $33M in Funding

Greek startup Achira AI has secured $33 million in funding from top investors, including Dimension, Nvidia, Amplify, and Compound. Achira aims to revolutionize AI-enabled drug development by integrating geometric deep learning, physics, quantum chemistry, and statistical mechanics to create advanced simulation models. This approach seeks to overcome limitations in current biomolecular simulations and machine learning models, accelerating the discovery of new molecules and treatments.

Endpoints News
Feb 21st, 2025
Nvidia-backed Achira debuts, blending AI and physics to model molecules

As he was testing new antivirals to halt a future pandemic, John Chodera encountered an unlikely set of new problems that ultimately helped lead to his new job. The computational ...